American Express (AXP) has experienced recent share price weakness, with a 30-day decline of 7.5%, despite strong longer-term returns. While one valuation narrative suggests AXP is 9.5% overvalued at $337.50 with a fair value of $308.19 due to growth and profitability assumptions, another discounted cash flow model indicates undervaluation with a fair value of $383.56. Investors are encouraged to consider both perspectives and assess their own growth and risk tolerances.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Assessing American Express (AXP) Valuation After Recent Share Price Weakness
American Express (AXP) has experienced recent share price weakness, with a 30-day decline of 7.5%, despite strong longer-term returns. While one valuation narrative suggests AXP is 9.5% overvalued at $337.50 with a fair value of $308.19 due to growth and profitability assumptions, another discounted cash flow model indicates undervaluation with a fair value of $383.56. Investors are encouraged to consider both perspectives and assess their own growth and risk tolerances.